SBSB
BMY icon

Sullivan, Bruyette, Speros & Blaney’s Bristol-Myers Squibb BMY Stock Holding History

Sullivan, Bruyette, Speros & Blaney’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$905K Buy
14,333
+2,938
+26% +$183K 0.04% 124
2020
Q4 		$707K Sell
11,395
-355
-3% -$21.8K 0.03% 137
2020
Q3 		$708K Buy
11,750
+4
+0% +$241 0.04% 121
2020
Q2 		$691K Sell
11,746
-643
-5% -$38.5K 0.04% 113
2020
Q1 		$691K Sell
12,389
-98
-0.8% -$5.99K 0.05% 104
2019
Q4 		$802K Buy
12,487
+1,402
+13% +$80.3K 0.04% 106
2019
Q3 		$562K Sell
11,085
-272
-2% -$12.8K 0.03% 122
2019
Q2 		$515K Buy
11,357
+405
+4% +$18.9K 0.03% 125
2019
Q1 		$523K Sell
10,952
-271
-2% -$13.5K 0.03% 120
2018
Q4 		$583K Buy
11,223
+9
+0.1% +$484 0.04% 98
2018
Q3 		$696K Sell
11,214
-1,773
-14% -$105K 0.06% 75
2018
Q2 		$719K Buy
12,987
+12
+0.1% +$648 0.07% 70
2018
Q1 		$821K Buy
12,975
+10
+0.1% +$643 0.08% 64
2017
Q4 		$795K Sell
12,965
-5,986
-32% -$374K 0.08% 70
2017
Q3 		$1.21M Sell
18,951
-767
-4% -$44.8K 0.12% 47
2017
Q2 		$1.1M Buy
19,718
+697
+4% +$37.9K 0.11% 50
2017
Q1 		$1.03M Buy
19,021
+1
+0% +$55 0.1% 46
2016
Q4 		$1.11M Hold
19,020
– – 0.11% 41
2016
Q3 		$1.03M Buy
19,020
+2,981
+19% +$191K 0.1% 45
2016
Q2 		$1.18M Buy
+16,039
New +$1.13M 0.12% 39

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sullivan, Bruyette, Speros & Blaney's BMY Position: Q1 2021 in Review

Sullivan, Bruyette, Speros & Blaney increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2021, buying an estimated $183K and bringing the position to 14,333 shares worth $905K. The position accounts for 0.04% of the portfolio, ranked #124.

Sullivan, Bruyette, Speros & Blaney first reported a position in BMY in Q2 2016 and has held it in 20 quarters since. The position peaked at $1.21M in Q3 2017. 2,369 funds tracked by Wall St. Rank hold BMY as of Q1 2021.

  • Sullivan, Bruyette, Speros & Blaney held 14,333 shares of Bristol-Myers Squibb worth $905K as of Q1 2021.
  • Sullivan, Bruyette, Speros & Blaney bought 2,938 Bristol-Myers Squibb shares in Q1 2021, an estimated $183K.
  • Bristol-Myers Squibb made up 0.04% of Sullivan, Bruyette, Speros & Blaney's portfolio in Q1 2021, its #124 holding.
  • Sullivan, Bruyette, Speros & Blaney first reported a position in Bristol-Myers Squibb in Q2 2016 and has held it in 20 quarters since.
  • Sullivan, Bruyette, Speros & Blaney's Bristol-Myers Squibb position peaked at $1.21M in Q3 2017.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2021, filed 10 May 2021.